#immunology
articles
Markets
argenx Ends Week at €745 After 7.4% Slide; Analyst Target Implies 20% Upside
The immunology group slipped 7.38% over five sessions to close at €745.00 on July 31, while holding a 3.93% gain for 202...
Companies
arGEN-X to Acquire Forte Biosciences in $2.2 Billion Immunology Pipeline Deal
Dutch biotech arGEN-X is buying US-based Forte Biosciences for $2.2 billion, adding a promising anti-CD122 antibody for ...